Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Orexo===OX390
Entity

Orexo===OX390

Tracked across 1 events · 7 articles · First seen Mar 06, 2026 · Last active Mar 06, 2026

Sentiment
20
Attention
2
Events
1
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 20
Business
Orexo R&D Day on Strategy and AmorphOX
Orexo===OX390 is a powder-based intranasal rescue medication candidate in development by Orexo for adulterated overdoses, highlighting Orexo's focus on life-saving medications.
Mar 06, 2026 · 7 articles
Relationships (4)
Orexo===OX640 ↔ Orexo===OX390 Unknown
Orexo===AmorphOX ↔ Orexo===OX390 Unknown
Nikolaj Sørensen ↔ Orexo===OX390 Unknown
Orexo developer of ↔ Orexo===OX390 Orexo is developing Orexo===OX390, a powder-based intranasal rescue medication c
NEWSDESK
Track Orexo===OX390 live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.